Open AccessEfficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience
Author(s) -
Emre Bılgın,
Furkan Ceylan,
E. Durán,
B. Farisoğulları,
Ertuğrul Çağrı Bölek,
G. K. Yardimci,
Levent Kılıç,
Ali Akdoğan,
Ömer Karadağ,
Şaziye Şule Apraş Bilgen,
Sedat Kiraz,
Ali İhsan Ertenli,
Umut Kalyoncu
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2007-123
Subject(s) - medicine , tofacitinib , discontinuation , adverse effect , rheumatoid arthritis , concomitant , hazard ratio , retention rate , proportional hazards model , logistic regression , confidence interval , computer security , computer science
To assess the real-life efficacy, retention rate, and safety data of tofacitinib in rheumatoid arthritis (RA) patients.